Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleDurable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.AuthorsUchimoto, Taizo; Tsuchida, Shuya; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hirasawa, Yosuke; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Saruta, Masanobu; Hashimoto, Mamoru; Higashio, Takuya; Matsuda, Takuya; Nishimura, Kazuki; Tsujino, Takuya; Nakamura, Ko; Fukushima, Tatsuo; Nishio, Kyosuke; Yamamoto, Shutaro; Iwatani, Kosuke; Urabe, FumihikoPublicationTargeted Oncology, 2024, Vol 19, Issue 3, p401ISSN1776-2596Publication typeArticleDOI10.1007/s11523-024-01047-y